Imexpharm Corp - Asset Resilience Ratio

Latest as of March 2026: 13.68%

Imexpharm Corp (IMP) has an Asset Resilience Ratio of 13.68% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₫386.02 Billion

≈ $14.67 Million USD Cash + Short-term Investments

Total Assets

₫2.82 Trillion

≈ $107.18 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Imexpharm Corp's Asset Resilience Ratio has changed over time. Check Imexpharm Corp (IMP) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Imexpharm Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IMP market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₫0.00	0%
Short-term Investments	₫386.02 Billion	13.68%
Total Liquid Assets	₫386.02 Billion	13.68%

Asset Resilience Insights

Moderate Liquidity: Imexpharm Corp has 13.68% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Imexpharm Corp Industry Peers by Asset Resilience Ratio

Compare Imexpharm Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Imexpharm Corp (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Imexpharm Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.62%	₫212.10 Billion ≈ $8.06 Million	₫2.78 Trillion ≈ $105.72 Million	+1.95pp
2024-12-31	5.67%	₫142.00 Billion ≈ $5.40 Million	₫2.50 Trillion ≈ $95.17 Million	+1.78pp
2023-12-31	3.89%	₫93.00 Billion ≈ $3.53 Million	₫2.39 Trillion ≈ $90.90 Million	-5.39pp
2022-12-31	9.28%	₫211.30 Billion ≈ $8.03 Million	₫2.28 Trillion ≈ $86.51 Million	+4.38pp
2021-12-31	4.90%	₫112.45 Billion ≈ $4.27 Million	₫2.29 Trillion ≈ $87.18 Million	+1.87pp
2020-12-31	3.03%	₫63.61 Billion ≈ $2.42 Million	₫2.10 Trillion ≈ $79.65 Million	+2.75pp
2019-12-31	0.28%	₫5.19 Billion ≈ $197.09K	₫1.85 Trillion ≈ $70.18 Million	--

pp = percentage points

About Imexpharm Corp

VN:IMP Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$205.38 Million

₫5.41 Trillion VND

Market Cap Rank

#16389 Global

#91 in Vietnam

Share Price

₫35100.00

Change (1 day)

-2.50%

52-Week Range

₫35000.00 - ₫56700.00

All Time High

₫97000.00